Compassion use has been rarely out of the news in the last year. Whilst recent high profile cases have involved children, compassionate use is by no means restricted to paediatrics, and stakeholders have much to learn from each other.
The idea that a treatment that has not yet completed clinical trials can be made available in specified circumstances for patients in dire need is an appealing but problematic one. ’When should this ‘work-around’ be applied and when should it not?’ is a question that troubles patients and their families, clinicians, ethics committee members, regulators and the developers of those treatments.
Who should authorise compassionate use – clinical ethics or research ethics committees, patients or the judiciary?
This meeting will offer much-needed education on (and discussion of) the concept of ‘compassionate use,’ at the boundary between medical research and clinical practice. We anticipate that the day will be of educational interest to clinicians, members of legal and regulatory professions,patient advocates, ethicists, and members of the press.
Speakers will address the issue from a number of relevant perspectives including: clinical, legal and regulatory, ethical, the media and commerce. The meeting is particularly relevant training for anyone who may potentially be involved in discussing, negotiating or reporting a ‘compassionate-use’ case.
Topics include:
Dr Paquita De Zulueta, President, Open Section, Royal Society of Medicine
Dr Andrew Papanikitas
Dr Nicola Stingelin
Dr Ketan Shah, Consultant Clinical Oncologist, Company Name Oxford University Hospitals NHS Foundation Trust
James Lawford Davies, Partner, Hempsons, London
Professor Dominic Wilkinson, Director and Professor of Medical Ethics, University of Oxford, Consultant in newborn intensive care, John Radcliffe Hospital
Dr Andrew Papanikitas, Nicola Stingelin, James Lawford Davies, Ketan Shah, Dominic Wilkinson
Dr Nicola Stingelin, Independent Research Ethics Advisor
Vikram Sachdeva, QC
Dr Anne-Marie Slowther, Reader in Clinical Ethics, Warwick Medical School and Clinical Ethicist, University Hospitals Coventry and Warwickshire NHS Trust
Dr Rav Seeruthen, Medical Director, Roche UK
Mr Tom Sheldon, Science Media Centre
Chair Dr Nicola Stingelin, Mr Vikram Sachdeva, Professor Anne Slowther, Dr Rav Seeruthun, Mr Tom Sheldon
Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE, United Kingdom
The SAFE-T Summit brings together world-renowned experts from within and outside the perioperative team. Speakers will highlight the importance of global equity, teamwork, surgical care, and perioperative safety through ethics, gender, diversity and social strategies.
Discuss perennial problems of 21st century healthcare: morale and self-care, moral distress sustainable goals and practical wisdom.
This meeting will consider the implications of the increased prevalence of health conditions that might impact on work, including co-morbidities, and the potential increased risks to health from working to an older age.
This meeting will bring together policy-makers, researchers, clinicians and other healthcare professionals to understand the climate for whistleblowers within the NHS.
